Johnson & Johnson reaches proposed $5.5 billion deal to resolve ovarian talc lawsuits

Johnson & Johnson reached a conditional deal with lead plaintiff firms to resolve remaining ovarian talc litigation, requiring at least 95% claimant participation.

• The agreement targets roughly 76,000 ovarian talc claims, aiming to end ongoing litigation costs and exposure.
• The settlement framework includes a USD 5.5 billion commitment; the first payment is capped at USD 3 billion in 2027, with no further payments before 2028.
• The move follows a federal MDL court order requiring plaintiffs to show why claims should not be dismissed for lack of specific causation proof.